What happens when you take prednisone with vitamin D?
Prednisone, like other glucocorticoids, has a complicated relationship with vitamin D metabolism. Rather than blocking vitamin D in any single step, prednisone tugs on the system at several points simultaneously. The net effect of long-term steroid therapy is lower circulating active vitamin D, reduced calcium absorption from the gut, and the cascade of bone loss that defines glucocorticoid-induced osteoporosis.
The mechanisms have been studied in cell, animal, and human models. Glucocorticoids appear to upregulate 24-hydroxylase, the enzyme that converts 25-hydroxyvitamin D into inactive metabolites for excretion. They may also blunt the vitamin D receptor's effect at the intestinal lining, so even normal vitamin D levels produce less calcium absorption than they would in a person not on steroids. The combined effect is a functional vitamin D resistance: the body needs more vitamin D activity to achieve the same outcome.
The clinical correlate of these mechanisms shows up in population data. Analysis of the National Health and Nutrition Examination Survey (NHANES) found that severe vitamin D deficiency (25-OH vitamin D below 10 ng/mL) was more than twice as common among children and adults reporting oral steroid use (11%) compared to non-users (5%). The doubled risk is exactly what would be predicted from the laboratory mechanisms.
Why is this important?
Vitamin D is the linchpin of the body's calcium economy. It enables intestinal calcium absorption, supports bone mineralization, and regulates parathyroid hormone. When vitamin D activity drops, calcium absorption drops, parathyroid hormone rises, and bone gets resorbed to maintain serum calcium levels.
For a patient on prednisone, vitamin D deficiency turns an already bone-hostile drug into a bone-catastrophic one. Prednisone alone causes rapid bone loss in the first 6 to 12 months of therapy. Layer vitamin D deficiency on top, and the bone loss accelerates further while fracture risk climbs. Because vertebral fractures from glucocorticoid-induced osteoporosis are often silent, patients may experience significant skeletal damage before anyone realizes the problem.
The relationship works in the opposite direction too: adequate vitamin D status partially protects against the bone effects of glucocorticoids. Meta-analyses have shown that calcium plus vitamin D supplementation reduces (though does not eliminate) bone loss in glucocorticoid-treated patients. Vitamin D supplementation is therefore standard of care for anyone on more than a brief course of systemic steroids.
What should you do?
If you have been prescribed prednisone or another systemic glucocorticoid at a dose of 2.5 mg/day or higher for a course expected to last 3 months or longer, vitamin D supplementation should be part of your treatment plan.
The American College of Rheumatology recommends at least 600 to 800 IU of vitamin D daily for adults on glucocorticoids, combined with 1,000 to 1,200 mg/day of total calcium. Vitamin D3 (cholecalciferol) is generally preferred over vitamin D2 (ergocalciferol) because D3 raises serum 25-OH vitamin D more efficiently.
For patients on long-term or high-dose steroid therapy, baseline measurement of serum 25-hydroxyvitamin D is reasonable, with a goal of maintaining levels of at least 30 ng/mL (75 nmol/L). Patients who are deficient at baseline may need higher loading doses (for example, 50,000 IU weekly for 8 to 12 weeks) followed by maintenance therapy of 1,000 to 2,000 IU daily.
Take vitamin D with a meal containing some fat, because it is fat-soluble and absorption improves with dietary fat. Vitamin D and calcium can be taken together (many supplements combine them), and there is no special timing requirement relative to prednisone itself.
Which specific products are affected?
All systemic glucocorticoids influence vitamin D metabolism: prednisone, prednisolone, methylprednisolone (Medrol), dexamethasone, hydrocortisone (at supraphysiologic doses), and triamcinolone. Inhaled and topical corticosteroids have much smaller systemic effects, but very high doses or long durations of inhaled steroids can also reduce bone density and warrant attention to vitamin D status.
Vitamin D supplements come in two forms: cholecalciferol (D3) from animal sources or lichen, and ergocalciferol (D2) from yeast or fungi. D3 is preferred for general supplementation; D2 is sometimes prescribed at high doses (50,000 IU capsules) for treating deficiency.
Combination calcium plus vitamin D supplements are widely available (Caltrate 600 + D, Os-Cal Calcium + D3, Citracal + D3) and are convenient for patients on prednisone, since both nutrients are needed.
Active vitamin D analogues such as calcitriol (the fully activated 1,25-dihydroxyvitamin D) and alfacalcidol are sometimes prescribed for patients with severe vitamin D resistance, advanced kidney disease, or other special situations. These require careful monitoring of serum calcium because they can cause hypercalcemia more readily than plain vitamin D.
Dietary sources of vitamin D include fatty fish (salmon, mackerel, sardines), egg yolks, fortified dairy and plant milks, fortified cereals, and UV-exposed mushrooms. Sunlight exposure also produces vitamin D in skin, but most adults on prednisone for chronic conditions do not get enough incidental sun exposure to reach adequate levels.
The bottom line
Prednisone accelerates vitamin D breakdown and impairs the vitamin D-driven calcium absorption process at the gut, doubling the rate of severe deficiency in oral steroid users. Take 600 to 800 IU of vitamin D3 daily alongside 1,000 to 1,200 mg of calcium, get your 25-OH vitamin D level checked if you are on prednisone long-term, and supplement more aggressively if you are found to be deficient.